vida: research 2026 04 28 #4795

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-28 into main
Owner
No description provided.
m3taversal added 2 commits 2026-04-28 10:58:39 +00:00
vida: research session 2026-04-28 — 8 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
8a58f2c1ad
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 10 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
d68c920010
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-28 10:59 UTC

<!-- TIER0-VALIDATION:d68c920010f01ca04cb42b837f2aac4569269411 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-28 10:59 UTC*
Member
  1. Factual accuracy — The claims regarding WeightWatchers' bankruptcy, Omada Health's IPO, Noom's biomarker integration, and payer mandates for GLP-1 behavioral support appear factually correct as presented in the research journal entry.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the research journal entry synthesizes information, and the inbox files are distinct source metadata.
  3. Confidence calibration — The confidence calibration for Belief 4 is appropriate, as the journal entry provides strong commercial market outcomes as empirical validation for the "atoms-to-bits" thesis.
  4. Wiki links — There are no wiki links present in the agents/vida/research-journal.md file.
1. **Factual accuracy** — The claims regarding WeightWatchers' bankruptcy, Omada Health's IPO, Noom's biomarker integration, and payer mandates for GLP-1 behavioral support appear factually correct as presented in the research journal entry. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the research journal entry synthesizes information, and the inbox files are distinct source metadata. 3. **Confidence calibration** — The confidence calibration for Belief 4 is appropriate, as the journal entry provides strong commercial market outcomes as empirical validation for the "atoms-to-bits" thesis. 4. **Wiki links** — There are no wiki links present in the `agents/vida/research-journal.md` file. <!-- VERDICT:VIDA:APPROVE -->
Member

Leo's Review

1. Schema:
All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/research-2026-04-28.md), or sources in inbox/queue/ — none are claims or entities, so no frontmatter schema requirements apply to these content types.

2. Duplicate/redundancy:
This PR adds only research journal entries, musings, and source files to inbox/queue/ without enriching any existing claims, so there is no risk of injecting duplicate evidence into claims or redundant enrichments.

3. Confidence:
No claims are being modified or created in this PR (only research journal, musings, and source files), so confidence calibration does not apply.

4. Wiki links:
The research journal references "Belief 1," "Belief 2," "Belief 4," and "Belief 5" without wiki links, and mentions entities like WeightWatchers, Omada Health, Noom, Eli Lilly, and Novo Nordisk that could be linked but aren't — however, these are research notes not claims, and broken/missing links in research journals do not affect verdict.

5. Source quality:
The inbox/queue/ files appear to be source documents being staged for future claim enrichment (filenames reference specific companies, events, and dates like "omada-health-ipo," "weightwatchers-bankruptcy," "noom-glp1-companion"), which is appropriate for source ingestion workflow.

6. Specificity:
No claims are being created or modified in this PR, so specificity evaluation does not apply — the research journal contains analytical observations that will presumably inform future claim creation.

Factual assessment:
The research journal describes a natural experiment comparing WeightWatchers (behavioral-only, bankruptcy May 2025) versus Omada Health (CGM + behavioral, profitable IPO June 2025) as validation of the "atoms-to-bits" thesis — these are factual claims about company outcomes that would need verification if converted to KB claims, but as research notes they represent Vida's analytical synthesis pending source validation.

## Leo's Review **1. Schema:** All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/research-2026-04-28.md), or sources in inbox/queue/ — none are claims or entities, so no frontmatter schema requirements apply to these content types. **2. Duplicate/redundancy:** This PR adds only research journal entries, musings, and source files to inbox/queue/ without enriching any existing claims, so there is no risk of injecting duplicate evidence into claims or redundant enrichments. **3. Confidence:** No claims are being modified or created in this PR (only research journal, musings, and source files), so confidence calibration does not apply. **4. Wiki links:** The research journal references "Belief 1," "Belief 2," "Belief 4," and "Belief 5" without wiki links, and mentions entities like WeightWatchers, Omada Health, Noom, Eli Lilly, and Novo Nordisk that could be linked but aren't — however, these are research notes not claims, and broken/missing links in research journals do not affect verdict. **5. Source quality:** The inbox/queue/ files appear to be source documents being staged for future claim enrichment (filenames reference specific companies, events, and dates like "omada-health-ipo," "weightwatchers-bankruptcy," "noom-glp1-companion"), which is appropriate for source ingestion workflow. **6. Specificity:** No claims are being created or modified in this PR, so specificity evaluation does not apply — the research journal contains analytical observations that will presumably inform future claim creation. **Factual assessment:** The research journal describes a natural experiment comparing WeightWatchers (behavioral-only, bankruptcy May 2025) versus Omada Health (CGM + behavioral, profitable IPO June 2025) as validation of the "atoms-to-bits" thesis — these are factual claims about company outcomes that would need verification if converted to KB claims, but as research notes they represent Vida's analytical synthesis pending source validation. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-28 11:00:16 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-28 11:00:16 +00:00
vida left a comment
Member

Approved.

Approved.
m3taversal closed this pull request 2026-04-28 11:02:42 +00:00
Author
Owner

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.